These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28822828)

  • 21. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arterial wave reflection during antihypertensive therapy with barnidipine: a 6-month, open-label study using an integrated cardiovascular ultrasound approach in patients with newly diagnosed hypertension.
    Palombo C; Malshi E; Morizzo C; Rakebrandt F; Corretti V; Santini F; Fraser AG; Kozakova M
    Clin Ther; 2009 Dec; 31(12):2873-85. PubMed ID: 20110026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness.
    Kampus P; Serg M; Kals J; Zagura M; Muda P; Karu K; Zilmer M; Eha J
    Hypertension; 2011 Jun; 57(6):1122-8. PubMed ID: 21536983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial.
    Hayer MK; Edwards NC; Slinn G; Moody WE; Steeds RP; Ferro CJ; Price AM; Andujar C; Dutton M; Webster R; Webb DJ; Semple S; MacIntyre I; Melville V; Wilkinson IB; Hiemstra TF; Wheeler DC; Herrey A; Grant M; Mehta S; Ives N; Townend JN
    Am Heart J; 2017 Sep; 191():37-46. PubMed ID: 28888268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of spironolactone in patients with resistant arterial hypertension in relation to baseline blood pressure and secondary causes of hypertension.
    Vaclavik J; Sedlak R; Jarkovsky J; Kocianova E; Taborsky M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Mar; 157(1):50-5. PubMed ID: 23128822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. True antihypertensive efficacy of sequential nephron blockade in patients with resistant hypertension and confirmed medication adherence.
    Beaussier H; Boutouyrie P; Bobrie G; Frank M; Laurent S; Coudoré F; Azizi M
    J Hypertens; 2015 Dec; 33(12):2526-33. PubMed ID: 26378683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of vascular phenotype using a novel very-high-resolution ultrasound technique in adolescents after aortic coarctation repair and/or stent implantation: relationship to central haemodynamics and left ventricular mass.
    Sarkola T; Redington AN; Slorach C; Hui W; Bradley T; Jaeggi E
    Heart; 2011 Nov; 97(21):1788-93. PubMed ID: 21795301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus: a double blind randomized clinical trial.
    Oxlund CS; Henriksen JE; Tarnow L; Schousboe K; Gram J; Jacobsen IA
    J Hypertens; 2013 Oct; 31(10):2094-102. PubMed ID: 24107738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of high central blood pressure in young with isolated systolic hypertension.
    Radchenko GD; Torbas OO; Sirenko YM
    Vasc Health Risk Manag; 2016; 12():321-8. PubMed ID: 27536127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparsion of central aortic pressure to brachial artery pressure in hypertensive patients on drug treatment: An observational study.
    Baba BA; Johan PT; Mohan JC
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S208-S212. PubMed ID: 30595260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EXCEED: Exforge-intensive control of hypertension to evaluate efficacy in diastolic dysfunction: study rationale, design, and participant characteristics.
    Hassanein A; Desai A; Verma A; Oparil S; Izzo J; Rocha R; Hilkert R; Seifu Y; Pitt B; Solomon S
    Ther Adv Cardiovasc Dis; 2009 Dec; 3(6):429-39. PubMed ID: 19638366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of Child and Adult Elevated Blood Pressure on Adult Arterial Stiffness: The Cardiovascular Risk in Young Finns Study.
    Aatola H; Koivistoinen T; Tuominen H; Juonala M; Lehtimäki T; Viikari JSA; Raitakari OT; Kähönen M; Hutri-Kähönen N
    Hypertension; 2017 Sep; 70(3):531-536. PubMed ID: 28674036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in the magnitude of wave reflection account for differential effects of amlodipine- versus atenolol-based regimens on central blood pressure: an Anglo-Scandinavian Cardiac Outcome Trial substudy.
    Manisty CH; Zambanini A; Parker KH; Davies JE; Francis DP; Mayet J; McG Thom SA; Hughes AD;
    Hypertension; 2009 Oct; 54(4):724-30. PubMed ID: 19704107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with high brachial-ankle pulse wave velocity in non-hypertensive and appropriately treated hypertensive patients with atherosclerotic risk factors.
    Ato D; Sawayama T
    Vasc Health Risk Manag; 2017; 13():383-392. PubMed ID: 29066906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity.
    Dhakam Z; McEniery CM; Yasmin ; Cockcroft JR; Brown MJ; Wilkinson IB
    Am J Hypertens; 2006 Feb; 19(2):214-9. PubMed ID: 16448896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aortic blood pressure and arterial stiffness in patients with controlled resistant and non-resistant hypertension.
    Cai A; Siddiqui M; Judd EK; Oparil S; Calhoun DA
    J Clin Hypertens (Greenwich); 2020 Feb; 22(2):167-173. PubMed ID: 32049430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia.
    Kanaki AI; Sarafidis PA; Georgianos PI; Kanavos K; Tziolas IM; Zebekakis PE; Lasaridis AN
    Am J Hypertens; 2013 May; 26(5):608-16. PubMed ID: 23449607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications.
    Ayala DE; Hermida RC; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):340-52. PubMed ID: 23077973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial.
    Staessen JA; Den Hond E; Celis H; Fagard R; Keary L; Vandenhoven G; O'Brien ET;
    JAMA; 2004 Feb; 291(8):955-64. PubMed ID: 14982911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of Central Blood Pressure to Hypertensive Target Organ Damages During Antihypertensive Treatment: The J-TOP Study.
    Shimizu M; Hoshide S; Ishikawa J; Yano Y; Eguchi K; Kario K
    Am J Hypertens; 2015 Aug; 28(8):980-6. PubMed ID: 25548141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.